These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23075235)

  • 41. Molecular decomposition of complex clinical phenotypes using biologically structured analysis of microarray data.
    Lottaz C; Spang R
    Bioinformatics; 2005 May; 21(9):1971-8. PubMed ID: 15677704
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiRNAs in cancer: non-coding RNAs as appealing biomarkers for malignancy.
    Morin P
    Cancer Biomark; 2012; 11(6):227-8. PubMed ID: 23248179
    [No Abstract]   [Full Text] [Related]  

  • 43. A cancer roadmap.
    Broude NE
    Expert Rev Mol Diagn; 2005 Mar; 5(2):121-2. PubMed ID: 15833040
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of steroid receptor coactivator-3 (SRC-3) in human malignant disease.
    Gojis O; Rudraraju B; Alifrangis C; Krell J; Libalova P; Palmieri C
    Eur J Surg Oncol; 2010 Mar; 36(3):224-9. PubMed ID: 19716257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA expression in colorectal cancer.
    Hogan NM; Joyce MR; Kerin MJ
    Cancer Biomark; 2012; 11(6):239-43. PubMed ID: 23248181
    [No Abstract]   [Full Text] [Related]  

  • 46. Current status of fluorescent in-situ hybridisation.
    Jain KK
    Med Device Technol; 2004 May; 15(4):14-7. PubMed ID: 15303557
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell adhesion molecules: role and clinical significance in cancer.
    Makrilia N; Kollias A; Manolopoulos L; Syrigos K
    Cancer Invest; 2009 Dec; 27(10):1023-37. PubMed ID: 19909018
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular markers for cancer prognosis and treatment: have we struck gold?
    Nowsheen S; Aziz K; Panayiotidis MI; Georgakilas AG
    Cancer Lett; 2012 Dec; 327(1-2):142-52. PubMed ID: 22120674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype.
    Jiang J; Zhang Y; Chuai S; Wang Z; Zheng D; Xu F; Zhang Y; Li C; Liang Y; Chen Z
    Oncogene; 2012 Feb; 31(6):671-82. PubMed ID: 21743497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MiRNAs as biomarkers and therapeutic targets in cancer.
    Heneghan HM; Miller N; Kerin MJ
    Curr Opin Pharmacol; 2010 Oct; 10(5):543-50. PubMed ID: 20541466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Missing the mark.
    Gewin V
    Nature; 2007 Oct; 449(7164):770-1. PubMed ID: 17968417
    [No Abstract]   [Full Text] [Related]  

  • 52. [Problems of tumor progression: doubts or hopes at the turn of the Millennium?].
    Tímár J
    Orv Hetil; 2000 Apr; 141(17):891-9. PubMed ID: 10827469
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic and cellular mechanisms of oncogenesis.
    Marshall C; Vousden K
    Curr Opin Genet Dev; 2011 Feb; 21(1):1-3. PubMed ID: 21273056
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical implications of tumor heterogeneity.
    Schilsky RL
    Haematol Blood Transfus; 1987; 31():278-82. PubMed ID: 3327773
    [No Abstract]   [Full Text] [Related]  

  • 55. Targeting molecular tumor types.
    Nat Genet; 2013 Oct; 45(10):1103. PubMed ID: 24071840
    [No Abstract]   [Full Text] [Related]  

  • 56. Reliable Biomarkers to Identify New and Recurrent Cancer.
    Sauter ER
    Eur J Breast Health; 2017 Oct; 13(4):162-167. PubMed ID: 29082372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The changing face of tumor phenotypes.
    Macfarlane R; Sauter ER
    Biomark Med; 2012 Oct; 6(5):563-6. PubMed ID: 23075235
    [No Abstract]   [Full Text] [Related]  

  • 58. Cancer stem cells and markers: new model of tumorigenesis with therapeutic implications.
    Natarajan TG; Ganesan N; Fitzgerald KT
    Cancer Biomark; 2010; 9(1-6):65-99. PubMed ID: 22112470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cancer epigenetics as biomarkers of clinical significance.
    Panayiotidis MI
    Cancer Lett; 2014 Jan; 342(2):168-9. PubMed ID: 24183850
    [No Abstract]   [Full Text] [Related]  

  • 60. [Novel tumor markers-circulating miRNA].
    Xie L; Qian XP; Liu BR
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):641-2. PubMed ID: 22340041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.